Patent Assignment
Reel/Frame 036875/0147
Assignment of Assignor's Interest
Recorded: 2015-10-15
Pages: 50
Assignor
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Executed: 2015-09-09
Assignee
COM AFFILIATION, INC.
1300 MORRIS PARK AVENUE, BRONX, NEW YORK, 10461
Covered Properties
(26)
Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-Egfr Therapy
Compounds and Methods for Detecting Ricin and Uses Thereof
Acyclic Amine Inhibitors of 5-Methytioadenosine Phosphorylase and Nucleosidase
Acyclic Amine Inhibitors of Nucleoside Phosphorylases and Hydrolases
Multi-Microrna Methods and Compositions
Small Molecule Inhibitors of BCL6
Biological markers for longevity and diseases and uses thereof
Detection of the Nucleolar Channel System of Human Endometrium and Uses Thereof
Azetidine Analogues of Nucleosidase and Phosphorylase Inhibitors
Second Generation Low Oxygen Affinity Pegylated Hemoglobins as Oxygen-Carrying Plasma Expanders
Mycobacterial Mutants Inducing Il-12
Methods for Determining Cytosine Methylation in Dna and Uses Thereof
Treatment of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury and Neurodegeneration with Humanin and Analogs Thereof
Fused Pyrimidines as Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Metastasis Specific Splice Variants of Mena and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Treatment of Autism Spectrum Disorders with Agents That Activate the Locus Coeruleus - Noradrenergic System
Use of Gamma Secretase Inhibitors and Notch Pathway Inhibitors for Treatment and Prevention of Renal Desease
Ketoconazole-Derivative Antagonist of Human Pregnane X Receptor and Uses Thereof
Fenretinide Derivatives and Uses Thereof as Therapeutic, Diagnostic and Imaging Agents
Methods and Compositions for Inhibition of BCL6 Repression
Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-Egfr Therapy
Tumor Microenvironment of Metastasis (Tmem) and Uses Thereof in Diagnosis, Prognosis and Treatment of Tumors
Anti-Peptide Antibodies That Cross React with Protective Antigen of Bacillus Anthracis and Uses Thereof
Methods for Determining Chemotherapeutic Agents Targeting Alpha-Glucan Pathways and Uses Thereof
Saporin-L1 inhibitors and uses thereof
Methods and Compositions for Inhibition of BCL6 Repression
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 7, 2009
From: PURPURA, DOMINICK P.; MEHLER, MARK F.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 023613/0449 →
Assignment of Assignor's Interest
Jan 27, 2010
From: SCHRAMM, VERN L.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 023856/0501 →
Assignment of Assignor's Interest
Feb 23, 2010
From: EVANS, GARY BRIAN; FURNEAUX, RICHARD HUBERT; GREATREX, BEN WILLIAM; TYLER, PETER CHARLES
To: INDUSTRIAL RESEARCH LIMITED
Reel/Frame 023975/0756 →
Assignment of Assignor's Interest
Nov 8, 2011
From: ZHU, LIANG; SUN, DAQIAN
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 027192/0147 →
Change of Name
Feb 26, 2015
From: INDUSTRIAL RESEARCH LIMITED
To: CALLAGHAN INNOVATION RESEARCH LIMITED
Reel/Frame 035101/0436 →
Assignment of Assignor's Interest
Mar 4, 2015
From: CALLAGHAN INNOVATION RESEARCH LIMITED
To: VICTORIA LINK LIMITED
Reel/Frame 035086/0004 →
Confirmatory License
Jun 5, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035837/0652 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036877/0835 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036878/0001 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0817 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0939 →
Change of Name
Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036900/0190 →
Merger and Change of Name
Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Confirmatory License
Apr 23, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 048976/0654 →
Release of Security Interest
Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
Security Interest
Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
Release of Security Interest
Apr 6, 2023
From: MIDCAP FINANCIAL TRUST
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 063348/0762 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
Confirmatory License
Jun 10, 2024
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 067676/0734 →